Buy Dopamantine Cas 39907-68-1

Buy Dopamantine Cas 39907-68-1

Dopamantine (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name; developmental code name SCH-15507; also known as N-adamantanoyl dopamine) is an antiparkinsonian drug of the adamantane group that developed for treatment of Parkinson’s disease but was never marketed.^{[1][2][3][4][5][6]} It was developed and studied in the 1970s and was said to have reached early clinical trials.^[1][6][4]

Dopamantine combines elements of the chemical structures of clinically used adamantane antiparkinsonian agents like amantadine and dopamine or levodopa (L-DOPA) into a single molecule.^[3][4] It is said to have been designed to help dopamine cross the blood–brain barrier via the lipophilic adamantane moiety.^[5] The drug is said to share pharmacological effects with amantadine.^[4] Another related compound is carmantadine, which is also an adamantane antiparkinsonian agent that was never marketed.^[4][6]